Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1993-03-10
1997-11-18
Phelan, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424448, 514946, 514947, A61F 1300
Patent
active
056885245
ABSTRACT:
Prazosin is formulated in solution with a akin permeation enhancer composition of: a sulfhydryl-containing compound, a fatty acid eater, and a polar solvent for transdermal administration to treat hypertension or benign prostatic hypertrophy. The formulation is employed in the form of a skin patch comprising (a) an impermeable backing layer, (b) a reservoir of the prazosin-enhancer solution, (c) a porous support member that retains the solution but is not a permeation barrier to the solution, a peripheral adhesive layer for affixing the patch to the skin, and a release liner layer.
REFERENCES:
patent: 4762851 (1988-08-01), Alexander et al.
patent: 4820720 (1989-04-01), Sanders et al.
patent: 4847250 (1989-07-01), Alexander et al.
patent: 4970206 (1990-11-01), Alexander et al.
patent: 5118845 (1992-06-01), Peck et al.
patent: 5474783 (1995-12-01), Miranda
Katz et al., "Enhanced skin permeation of Prazosin by transcutol-oleic acid mixture" Proceed. Intern. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Inc., (1991) 18:533-534.
Tenjarla, S.N., "Transdermal drug delivery of Prazosin" Pharm. Res. (1990) 7(9):S-189 (abstract No. PDD7312).
Hsu Tsung-Min
Roos Eric J.
Cygnus Inc.
Phelan D. Gabrielle
LandOfFree
Transdermal formulations for administering prazosin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal formulations for administering prazosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulations for administering prazosin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1563881